Clinical Trial Update: Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating topical sildenafil for palmar-plantar erythrodysesthesia (hand-foot syndrome) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand-foot Syndrome
• Palmar-plantar Erythrodysesthesia

Drugs mentioned

• Topical sildenafil (sildenafil)

Snippet

Sponsor: Duke University | Conditions: Hand Foot Syndrome, Palmar Plantar Erythrodysesthesia | Phase 1 | Status: COMPLETED